In the last decade, several cardiovascular outcomes trials (CVOT) have been conducted in order to explore cardiovascular benefit of GLP-1 receptor agonists
Sheer coverage, Smooth, colorless finish, Hypoallergenic, Allergy-tested, & Dermatologist-tested
Individuals recovering from laser treatment, microneedling, or chemical peels
Clinical Update 8/29/2024 Gluten in Supplements and Prescription Pills
Who Might Benefit From Dual-Compound Semaglutide and Tirzepatide Therapy Patients who benefit most from dual-compound GLP-1 protocols typically have high baseline weight, comorbid type 2 diabetes, a family history of metabolic disease, or prior inadequate response to single-agent therapy
Why choose BHH for GLP-1+GIP